Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 82 | 473 | 289 | 7,841 | -9,244 |
| Other Working Capital | 62 | -1,217 | -4,095 | 12,241 | -7,455 |
| Other Operating Activity | -7,954 | -7,476 | -10,480 | -61,098 | -7,120 |
| Operating Cash Flow | $-7,810 | $-8,220 | $-14,286 | $-41,016 | $-23,819 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | -13 | -6 | -15 | -39 |
| Purchase Of Investment | N/A | -1,500 | -3,750 | N/A | N/A |
| Sale Of Investment | 1,500 | 3,750 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -12 | -69 | 0 | -18 | -37 |
| Other Investing Activity | 441 | 642 | 140 | 12 | 31 |
| Investing Cash Flow | $1,835 | $2,810 | $-3,616 | $-21 | $-45 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13 | 0 | 1 | 14 | 99,784 |
| Other Financing Activity | 0 | 0 | 0 | -126 | -3,398 |
| Financing Cash Flow | $13 | $0 | $1 | $-112 | $96,386 |
| Beginning Cash Position | 10,516 | 15,926 | 33,827 | 74,976 | 2,454 |
| End Cash Position | 4,554 | 10,516 | 15,926 | 33,827 | 74,976 |
| Net Cash Flow | $-5,962 | $-5,410 | $-17,901 | $-41,149 | $72,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,810 | -8,220 | -14,286 | -41,016 | -23,819 |
| Capital Expenditure | -106 | -82 | -6 | -33 | -76 |
| Free Cash Flow | -7,916 | -8,302 | -14,292 | -41,049 | -23,895 |